<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;ff=20250303131430&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;ff=20250303131430&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Mon, 03 Mar 2025 18:14:32 +0000</lastbuilddate>
<pubDate>Mon, 03 Mar 2025 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Intestinal Microbiota Contributes to the Development of Cardiovascular Inflammation and Vasculitis in Mice</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40026151/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This study reveals an underappreciated gut microbiota-cardiovascular inflammation axis in Kawasaki disease vasculitis pathogenesis and identifies specific intestinal commensals that regulate vasculitis in mice by producing metabolites or via extracellular proteins capable of enhancing and supporting gut barrier function.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 3. doi: 10.1161/CIRCRESAHA.124.325079. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Alterations in the intestinal microbiota contribute to the pathogenesis of various cardiovascular disorders, but how they affect the development of Kawasaki disease, an acute pediatric vasculitis, remains unclear. Here, using a murine model mimicking Kawasaki disease vasculitis, we assessed the contribution of the intestinal microbiota to the development of vascular inflammation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: We report that depleting the gut microbiota reduces the development of cardiovascular inflammation in a murine model mimicking Kawasaki disease vasculitis. The development of cardiovascular lesions was associated with alterations in the intestinal microbiota composition and, notably, a decreased abundance of <i>Akkermansia muciniphila</i> and <i>Faecalibacterium prausnitzii</i>. Oral supplementation with either of these live or pasteurized individual bacteria or with short-chain fatty acids produced by them attenuated cardiovascular inflammation, as reflected by decreased local immune cell infiltrations. Treatment with Amuc_1100, the TLR-2 signaling outer membrane protein from <i>Akkermansia muciniphila</i>, also reduced the severity of vascular inflammation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study reveals an underappreciated gut microbiota-cardiovascular inflammation axis in Kawasaki disease vasculitis pathogenesis and identifies specific intestinal commensals that regulate vasculitis in mice by producing metabolites or via extracellular proteins capable of enhancing and supporting gut barrier function.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40026151/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40026151</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325079>10.1161/CIRCRESAHA.124.325079</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40026151</guid>
<pubDate>Mon, 03 Mar 2025 06:00:00 -0500</pubDate>
<dc:creator>Prasant K Jena</dc:creator>
<dc:creator>Daiko Wakita</dc:creator>
<dc:creator>Angela C Gomez</dc:creator>
<dc:creator>Thacyana T Carvalho</dc:creator>
<dc:creator>Asli E Atici</dc:creator>
<dc:creator>Emily Aubuchon</dc:creator>
<dc:creator>Meena Narayanan</dc:creator>
<dc:creator>Youngho Lee</dc:creator>
<dc:creator>Michael C Fishbein</dc:creator>
<dc:creator>Yoshihiro Takasato</dc:creator>
<dc:creator>Yosuke Kurashima</dc:creator>
<dc:creator>Hiroshi Kiyono</dc:creator>
<dc:creator>Patrice D Cani</dc:creator>
<dc:creator>Willem M de Vos</dc:creator>
<dc:creator>David M Underhill</dc:creator>
<dc:creator>Suzanne Devkota</dc:creator>
<dc:creator>Shuang Chen</dc:creator>
<dc:creator>Kenichi Shimada</dc:creator>
<dc:creator>Timothy R Crother</dc:creator>
<dc:creator>Moshe Arditi</dc:creator>
<dc:creator>Magali Noval Rivas</dc:creator>
<dc:date>2025-03-03</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Intestinal Microbiota Contributes to the Development of Cardiovascular Inflammation and Vasculitis in Mice</dc:title>
<dc:identifier>pmid:40026151</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325079</dc:identifier>
</item>
<item>
<title>GOLM1 Promotes Atherogenesis by Activating Macrophage EGFR-ERK Signaling Cascade</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40026146/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: GOLM1 is an atherogenic mediator and a promising therapeutic target for the intervention of atherosclerotic diseases.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Mar 3. doi: 10.1161/CIRCRESAHA.124.325880. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Atherosclerosis is a chronic inflammatory disease. GOLM1 (Golgi membrane protein 1) is an inflammation-responsive protein and a mediator in some inflammation-associated pathological processes. Because we found a positive correlation between GOLM1 expression and atherosclerosis progression by checking the gene expression data set of human atherosclerotic lesions, we explored the potential significance of GOLM1 in atherosclerosis in this study.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: GOLM1 levels in serums and lesions of patients with atherosclerosis and mice with atherosclerosis were examined by immunostaining and ELISA. Gain-of-function and loss-of-function approaches were used to study the impacts of GOLM1 in inflammation and atherogenesis of <i>Apoe</i><sup>-/-</sup> mice on a Western diet. The effects of GOLM1 on macrophage behaviors were determined by OxLDL (oxidized low-density lipoprotein) uptake assay, single-cell sequencing analysis, global phosphoproteomics analysis, and molecular biological techniques. The therapeutic potential of GOLM1 neutralization for atherosclerosis was evaluated in <i>Apoe</i><sup>-/-</sup> mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: GOLM1 was elevated in serums and lesions of patients with atherosclerosis and mice with atherosclerosis. Global deletion of GOLM1 ameliorated mouse inflammation and atherosclerosis, while knock-in of GOLM1 exacerbated these pathological manifestations. Furthermore, hepatic GOLM1 deletion reduced circulating GOLM1 and attenuated atherogenesis. Mechanistically, the expression and secretion of GOLM1 were induced in multiple mouse tissues by atherogenic stimulus, leading to the elevation of extracellular GOLM1. Extracellular GOLM1 then stimulated ERK (extracellular signal-regulated kinase) signaling cascade by binding to its putative receptor EGFR (epidermal growth factor receptor) to promote macrophage uptake of LDL (low-density lipoprotein) and enhance the corresponding macrophage immune response. Moreover, neutralizing GOLM1 by an antibody suppressed mouse inflammation and atherogenesis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: GOLM1 is an atherogenic mediator and a promising therapeutic target for the intervention of atherosclerotic diseases.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40026146/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40026146</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325880>10.1161/CIRCRESAHA.124.325880</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40026146</guid>
<pubDate>Mon, 03 Mar 2025 06:00:00 -0500</pubDate>
<dc:creator>Xiaochen Gai</dc:creator>
<dc:creator>Fangming Liu</dc:creator>
<dc:creator>Yixin Chen</dc:creator>
<dc:creator>Baohui Zhang</dc:creator>
<dc:creator>Yinliang Zhang</dc:creator>
<dc:creator>Yuting Wu</dc:creator>
<dc:creator>Shuhui Yang</dc:creator>
<dc:creator>Linlin Chen</dc:creator>
<dc:creator>Weiwei Deng</dc:creator>
<dc:creator>Yuan Wang</dc:creator>
<dc:creator>Shuiyun Wang</dc:creator>
<dc:creator>Cuntao Yu</dc:creator>
<dc:creator>Jie Du</dc:creator>
<dc:creator>Zhengyi Zhang</dc:creator>
<dc:creator>Jing Wang</dc:creator>
<dc:creator>Hongbing Zhang</dc:creator>
<dc:date>2025-03-03</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>GOLM1 Promotes Atherogenesis by Activating Macrophage EGFR-ERK Signaling Cascade</dc:title>
<dc:identifier>pmid:40026146</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325880</dc:identifier>
</item>
<item>
<title>Spatiotemporal modeling of molecular holograms</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40024251/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Mar 1:S0092-8674(25)00253-3. doi: 10.1016/j.cell.2025.02.026. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40024251/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40024251</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.02.026>10.1016/j.cell.2025.02.026</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40024251</guid>
<pubDate>Sun, 02 Mar 2025 06:00:00 -0500</pubDate>
<dc:creator>Xiaojie Qiu</dc:creator>
<dc:creator>Daniel Y Zhu</dc:creator>
<dc:creator>Yifan Lu</dc:creator>
<dc:creator>Jiajun Yao</dc:creator>
<dc:creator>Zehua Jing</dc:creator>
<dc:creator>Kyung Hoi Min</dc:creator>
<dc:creator>Mengnan Cheng</dc:creator>
<dc:creator>Hailin Pan</dc:creator>
<dc:creator>Lulu Zuo</dc:creator>
<dc:creator>Samuel King</dc:creator>
<dc:creator>Qi Fang</dc:creator>
<dc:creator>Huiwen Zheng</dc:creator>
<dc:creator>Mingyue Wang</dc:creator>
<dc:creator>Shuai Wang</dc:creator>
<dc:creator>Qingquan Zhang</dc:creator>
<dc:creator>Sichao Yu</dc:creator>
<dc:creator>Sha Liao</dc:creator>
<dc:creator>Chao Liu</dc:creator>
<dc:creator>Xinchao Wu</dc:creator>
<dc:creator>Yiwei Lai</dc:creator>
<dc:creator>Shijie Hao</dc:creator>
<dc:creator>Zhewei Zhang</dc:creator>
<dc:creator>Liang Wu</dc:creator>
<dc:creator>Yong Zhang</dc:creator>
<dc:creator>Mei Li</dc:creator>
<dc:creator>Zhencheng Tu</dc:creator>
<dc:creator>Jinpei Lin</dc:creator>
<dc:creator>Zhuoxuan Yang</dc:creator>
<dc:creator>Yuxiang Li</dc:creator>
<dc:creator>Ying Gu</dc:creator>
<dc:creator>David Ellison</dc:creator>
<dc:creator>Yuancheng Ryan Lu</dc:creator>
<dc:creator>Qinan Hu</dc:creator>
<dc:creator>Yuhui Hu</dc:creator>
<dc:creator>Ao Chen</dc:creator>
<dc:creator>Longqi Liu</dc:creator>
<dc:creator>Jonathan S Weissman</dc:creator>
<dc:creator>Jiayi Ma</dc:creator>
<dc:creator>Xun Xu</dc:creator>
<dc:creator>Shiping Liu</dc:creator>
<dc:creator>Yinqi Bai</dc:creator>
<dc:date>2025-03-02</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Spatiotemporal modeling of molecular holograms</dc:title>
<dc:identifier>pmid:40024251</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.02.026</dc:identifier>
</item>
<item>
<title>A deep learning strategy to identify cell types across species from high-density extracellular recordings</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40023155/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>High-density probes allow electrophysiological recordings from many neurons simultaneously across entire brain circuits but fail to reveal cell type. Here, we develop a strategy to identify cell types from extracellular recordings in awake animals and reveal the computational roles of neurons with distinct functional, molecular, and anatomical properties. We combine optogenetics and pharmacology using the cerebellum as a testbed to generate a curated ground-truth library of electrophysiological...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 25:S0092-8674(25)00110-2. doi: 10.1016/j.cell.2025.01.041. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">High-density probes allow electrophysiological recordings from many neurons simultaneously across entire brain circuits but fail to reveal cell type. Here, we develop a strategy to identify cell types from extracellular recordings in awake animals and reveal the computational roles of neurons with distinct functional, molecular, and anatomical properties. We combine optogenetics and pharmacology using the cerebellum as a testbed to generate a curated ground-truth library of electrophysiological properties for Purkinje cells, molecular layer interneurons, Golgi cells, and mossy fibers. We train a semi-supervised deep learning classifier that predicts cell types with greater than 95% accuracy based on the waveform, discharge statistics, and layer of the recorded neuron. The classifier's predictions agree with expert classification on recordings using different probes, in different laboratories, from functionally distinct cerebellar regions, and across species. Our classifier extends the power of modern dynamical systems analyses by revealing the unique contributions of simultaneously recorded cell types during behavior.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40023155/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40023155</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.041>10.1016/j.cell.2025.01.041</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40023155</guid>
<pubDate>Sat, 01 Mar 2025 06:00:00 -0500</pubDate>
<dc:creator>Maxime Beau</dc:creator>
<dc:creator>David J Herzfeld</dc:creator>
<dc:creator>Francisco Naveros</dc:creator>
<dc:creator>Marie E Hemelt</dc:creator>
<dc:creator>Federico D'Agostino</dc:creator>
<dc:creator>Marlies Oostland</dc:creator>
<dc:creator>Alvaro Sánchez-López</dc:creator>
<dc:creator>Young Yoon Chung</dc:creator>
<dc:creator>Michael Maibach</dc:creator>
<dc:creator>Stephen Kyranakis</dc:creator>
<dc:creator>Hannah N Stabb</dc:creator>
<dc:creator>M Gabriela Martínez Lopera</dc:creator>
<dc:creator>Agoston Lajko</dc:creator>
<dc:creator>Marie Zedler</dc:creator>
<dc:creator>Shogo Ohmae</dc:creator>
<dc:creator>Nathan J Hall</dc:creator>
<dc:creator>Beverley A Clark</dc:creator>
<dc:creator>Dana Cohen</dc:creator>
<dc:creator>Stephen G Lisberger</dc:creator>
<dc:creator>Dimitar Kostadinov</dc:creator>
<dc:creator>Court Hull</dc:creator>
<dc:creator>Michael Häusser</dc:creator>
<dc:creator>Javier F Medina</dc:creator>
<dc:date>2025-03-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A deep learning strategy to identify cell types across species from high-density extracellular recordings</dc:title>
<dc:identifier>pmid:40023155</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.041</dc:identifier>
</item>
<item>
<title>HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40023154/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>Clear cell renal cell carcinoma (ccRCC), despite having a low mutational burden, is considered immunogenic because it occasionally undergoes spontaneous regressions and often responds to immunotherapies. The signature lesion in ccRCC is inactivation of the VHL tumor suppressor gene and consequent upregulation of the HIF transcription factor. An earlier case report described a ccRCC patient who was cured by an allogeneic stem cell transplant and later found to have donor-derived T cells that...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 25:S0092-8674(25)00156-4. doi: 10.1016/j.cell.2025.01.046. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Clear cell renal cell carcinoma (ccRCC), despite having a low mutational burden, is considered immunogenic because it occasionally undergoes spontaneous regressions and often responds to immunotherapies. The signature lesion in ccRCC is inactivation of the VHL tumor suppressor gene and consequent upregulation of the HIF transcription factor. An earlier case report described a ccRCC patient who was cured by an allogeneic stem cell transplant and later found to have donor-derived T cells that recognized a ccRCC-specific peptide encoded by a HIF-responsive endogenous retrovirus (ERV), ERVE-4. We report that ERVE-4 is one of many ERVs that are induced by HIF, translated into HLA-bound peptides in ccRCCs, and capable of generating antigen-specific T cell responses. Moreover, ERV expression can be induced in non-ccRCC tumors with clinical-grade HIF stabilizers. These findings have implications for leveraging ERVs for cancer immunotherapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40023154/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40023154</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.046>10.1016/j.cell.2025.01.046</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40023154</guid>
<pubDate>Sat, 01 Mar 2025 06:00:00 -0500</pubDate>
<dc:creator>Qinqin Jiang</dc:creator>
<dc:creator>David A Braun</dc:creator>
<dc:creator>Karl R Clauser</dc:creator>
<dc:creator>Vijyendra Ramesh</dc:creator>
<dc:creator>Nitin H Shirole</dc:creator>
<dc:creator>Joseph E Duke-Cohan</dc:creator>
<dc:creator>Nancy Nabilsi</dc:creator>
<dc:creator>Nicholas J Kramer</dc:creator>
<dc:creator>Cleo Forman</dc:creator>
<dc:creator>Isabelle E Lippincott</dc:creator>
<dc:creator>Susan Klaeger</dc:creator>
<dc:creator>Kshiti M Phulphagar</dc:creator>
<dc:creator>Vipheaviny Chea</dc:creator>
<dc:creator>Nawoo Kim</dc:creator>
<dc:creator>Allison P Vanasse</dc:creator>
<dc:creator>Eddy Saad</dc:creator>
<dc:creator>Teagan Parsons</dc:creator>
<dc:creator>Melissa Carr-Reynolds</dc:creator>
<dc:creator>Isabel Carulli</dc:creator>
<dc:creator>Katarina Pinjusic</dc:creator>
<dc:creator>Yijia Jiang</dc:creator>
<dc:creator>Rong Li</dc:creator>
<dc:creator>Sudeepa Syamala</dc:creator>
<dc:creator>Suzanna Rachimi</dc:creator>
<dc:creator>Eva K Verzani</dc:creator>
<dc:creator>Jonathan D Stevens</dc:creator>
<dc:creator>William J Lane</dc:creator>
<dc:creator>Sabrina Y Camp</dc:creator>
<dc:creator>Kevin Meli</dc:creator>
<dc:creator>Melissa B Pappalardi</dc:creator>
<dc:creator>Zachary T Herbert</dc:creator>
<dc:creator>Xintao Qiu</dc:creator>
<dc:creator>Paloma Cejas</dc:creator>
<dc:creator>Henry W Long</dc:creator>
<dc:creator>Sachet A Shukla</dc:creator>
<dc:creator>Eliezer M Van Allen</dc:creator>
<dc:creator>Toni K Choueiri</dc:creator>
<dc:creator>L Stirling Churchman</dc:creator>
<dc:creator>Jennifer G Abelin</dc:creator>
<dc:creator>Cagan Gurer</dc:creator>
<dc:creator>Gavin MacBeath</dc:creator>
<dc:creator>Richard W Childs</dc:creator>
<dc:creator>Steven A Carr</dc:creator>
<dc:creator>Derin B Keskin</dc:creator>
<dc:creator>Catherine J Wu</dc:creator>
<dc:creator>William G Kaelin</dc:creator>
<dc:date>2025-03-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy</dc:title>
<dc:identifier>pmid:40023154</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.046</dc:identifier>
</item>
<item>
<title>Safeguarding the future of biomedical science in the United States</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40023153/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>NIH's abrupt decision to cap indirect cost reimbursement at 15% threatens the critical infrastructure supporting groundbreaking biomedical research in the United States. This policy jeopardizes America's global leadership in science and medicine. Urgent action is needed to advocate for its immediate and permanent reversal to protect the future of science.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 28:S0092-8674(25)00212-0. doi: 10.1016/j.cell.2025.02.024. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">NIH's abrupt decision to cap indirect cost reimbursement at 15% threatens the critical infrastructure supporting groundbreaking biomedical research in the United States. This policy jeopardizes America's global leadership in science and medicine. Urgent action is needed to advocate for its immediate and permanent reversal to protect the future of science.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40023153/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40023153</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.02.024>10.1016/j.cell.2025.02.024</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40023153</guid>
<pubDate>Sat, 01 Mar 2025 06:00:00 -0500</pubDate>
<dc:creator>Tom Maniatis</dc:creator>
<dc:date>2025-03-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Safeguarding the future of biomedical science in the United States</dc:title>
<dc:identifier>pmid:40023153</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.02.024</dc:identifier>
</item>
<item>
<title>Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40023152/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>Vitamin C (vitC) is essential for health and shows promise in treating diseases like cancer, yet its mechanisms remain elusive. Here, we report that vitC directly modifies lysine residues to form "vitcyl-lysine"-a process termed vitcylation. Vitcylation occurs in a dose-, pH-, and sequence-dependent manner in both cell-free systems and living cells. Mechanistically, vitC vitcylates signal transducer and activator of transcription-1 (STAT1)- lysine-298 (K298), impairing its interaction with T...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 27:S0092-8674(25)00145-X. doi: 10.1016/j.cell.2025.01.043. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Vitamin C (vitC) is essential for health and shows promise in treating diseases like cancer, yet its mechanisms remain elusive. Here, we report that vitC directly modifies lysine residues to form "vitcyl-lysine"-a process termed vitcylation. Vitcylation occurs in a dose-, pH-, and sequence-dependent manner in both cell-free systems and living cells. Mechanistically, vitC vitcylates signal transducer and activator of transcription-1 (STAT1)- lysine-298 (K298), impairing its interaction with T cell protein-tyrosine phosphatase (TCPTP) and preventing STAT1-Y701 dephosphorylation. This leads to enhanced STAT1-mediated interferon (IFN) signaling in tumor cells, increased major histocompatibility complex (MHC)/human leukocyte antigen (HLA) class I expression, and activation of anti-tumor immunity in vitro and in vivo. The discovery of vitcylation as a distinctive post-translational modification provides significant insights into vitC's cellular function and therapeutic potential, opening avenues for understanding its biological effects and applications in disease treatment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40023152/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40023152</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.043>10.1016/j.cell.2025.01.043</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40023152</guid>
<pubDate>Sat, 01 Mar 2025 06:00:00 -0500</pubDate>
<dc:creator>Xiadi He</dc:creator>
<dc:creator>Qiwei Wang</dc:creator>
<dc:creator>Xin Cheng</dc:creator>
<dc:creator>Weihua Wang</dc:creator>
<dc:creator>Yutong Li</dc:creator>
<dc:creator>Yabing Nan</dc:creator>
<dc:creator>Jiang Wu</dc:creator>
<dc:creator>Bingqiu Xiu</dc:creator>
<dc:creator>Tao Jiang</dc:creator>
<dc:creator>Johann S Bergholz</dc:creator>
<dc:creator>Hao Gu</dc:creator>
<dc:creator>Fuhui Chen</dc:creator>
<dc:creator>Guangjian Fan</dc:creator>
<dc:creator>Lianhui Sun</dc:creator>
<dc:creator>Shaozhen Xie</dc:creator>
<dc:creator>Junjie Zou</dc:creator>
<dc:creator>Sheng Lin</dc:creator>
<dc:creator>Yun Wei</dc:creator>
<dc:creator>James Lee</dc:creator>
<dc:creator>John M Asara</dc:creator>
<dc:creator>Ke Zhang</dc:creator>
<dc:creator>Lewis C Cantley</dc:creator>
<dc:creator>Jean J Zhao</dc:creator>
<dc:date>2025-03-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response</dc:title>
<dc:identifier>pmid:40023152</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.043</dc:identifier>
</item>
<item>
<title>Epigenetic editing in cardiovascular medicine: moving beyond the hype</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40021936/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Feb 28. doi: 10.1038/s41569-025-01143-0. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40021936/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40021936</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01143-0>10.1038/s41569-025-01143-0</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40021936</guid>
<pubDate>Fri, 28 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Luca Chiapperino</dc:creator>
<dc:creator>Michelle Habets</dc:creator>
<dc:creator>Francesco Paneni</dc:creator>
<dc:date>2025-02-28</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Epigenetic editing in cardiovascular medicine: moving beyond the hype</dc:title>
<dc:identifier>pmid:40021936</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01143-0</dc:identifier>
</item>
<item>
<title>RNA-binding proteins and glycoRNAs form domains on the cell surface for cell-penetrating peptide entry</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40020667/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>The composition and organization of the cell surface determine how cells interact with their environment. Traditionally, glycosylated transmembrane proteins were thought to be the major constituents of the external surface of the plasma membrane. Here, we provide evidence that a group of RNA-binding proteins (RBPs) is present on the surface of living cells. These cell-surface RBPs (csRBPs) precisely organize into well-defined nanoclusters enriched for multiple RBPs and glycoRNAs, and their...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 21:S0092-8674(25)00109-6. doi: 10.1016/j.cell.2025.01.040. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The composition and organization of the cell surface determine how cells interact with their environment. Traditionally, glycosylated transmembrane proteins were thought to be the major constituents of the external surface of the plasma membrane. Here, we provide evidence that a group of RNA-binding proteins (RBPs) is present on the surface of living cells. These cell-surface RBPs (csRBPs) precisely organize into well-defined nanoclusters enriched for multiple RBPs and glycoRNAs, and their clustering can be disrupted by extracellular RNase addition. These glycoRNA-csRBP clusters further serve as sites of cell-surface interaction for the cell-penetrating peptide trans-activator of transcription (TAT). Removal of RNA from the cell surface, or loss of RNA-binding activity by TAT, causes defects in TAT cell internalization. Together, we provide evidence of an expanded view of the cell surface by positioning glycoRNA-csRBP clusters as a regulator of communication between cells and the extracellular environment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40020667/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40020667</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.040>10.1016/j.cell.2025.01.040</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40020667</guid>
<pubDate>Fri, 28 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Jonathan Perr</dc:creator>
<dc:creator>Andreas Langen</dc:creator>
<dc:creator>Karim Almahayni</dc:creator>
<dc:creator>Gianluca Nestola</dc:creator>
<dc:creator>Peiyuan Chai</dc:creator>
<dc:creator>Charlotta G Lebedenko</dc:creator>
<dc:creator>Regan F Volk</dc:creator>
<dc:creator>Diego Detrés</dc:creator>
<dc:creator>Reese M Caldwell</dc:creator>
<dc:creator>Malte Spiekermann</dc:creator>
<dc:creator>Helena Hemberger</dc:creator>
<dc:creator>Namita Bisaria</dc:creator>
<dc:creator>Toshihiko Aiba</dc:creator>
<dc:creator>Francisco J Sánchez-Rivera</dc:creator>
<dc:creator>Konstantinos Tzelepis</dc:creator>
<dc:creator>Eliezer Calo</dc:creator>
<dc:creator>Leonhard Möckl</dc:creator>
<dc:creator>Balyn W Zaro</dc:creator>
<dc:creator>Ryan A Flynn</dc:creator>
<dc:date>2025-02-28</dc:date>
<dc:source>Cell</dc:source>
<dc:title>RNA-binding proteins and glycoRNAs form domains on the cell surface for cell-penetrating peptide entry</dc:title>
<dc:identifier>pmid:40020667</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.040</dc:identifier>
</item>
<item>
<title>The International Space Station has a unique and extreme microbial and chemical environment driven by use patterns</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40020666/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>Space habitation provides unique challenges in built environments isolated from Earth. We produced a 3D map of the microbes and metabolites throughout the United States Orbital Segment (USOS) of the International Space Station (ISS) with 803 samples collected during space flight, including controls. We find that the use of each of the nine sampled modules within the ISS strongly drives the microbiology and chemistry of the habitat. Relating the microbiology to other Earth habitats, we find that,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Feb 21:S0092-8674(25)00108-4. doi: 10.1016/j.cell.2025.01.039. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Space habitation provides unique challenges in built environments isolated from Earth. We produced a 3D map of the microbes and metabolites throughout the United States Orbital Segment (USOS) of the International Space Station (ISS) with 803 samples collected during space flight, including controls. We find that the use of each of the nine sampled modules within the ISS strongly drives the microbiology and chemistry of the habitat. Relating the microbiology to other Earth habitats, we find that, as with human microbiota, built environment microbiota also align naturally along an axis of industrialization, with the ISS providing an extreme example of an industrialized environment. We demonstrate the utility of culture-independent sequencing for microbial risk monitoring, especially as the location of sequencing moves to space. The resulting resource of chemistry and microbiology in the space-built environment will guide long-term efforts to maintain human health in space for longer durations.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40020666/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40020666</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.01.039>10.1016/j.cell.2025.01.039</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40020666</guid>
<pubDate>Fri, 28 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Rodolfo A Salido</dc:creator>
<dc:creator>Haoqi Nina Zhao</dc:creator>
<dc:creator>Daniel McDonald</dc:creator>
<dc:creator>Helena Mannochio-Russo</dc:creator>
<dc:creator>Simone Zuffa</dc:creator>
<dc:creator>Renee E Oles</dc:creator>
<dc:creator>Allegra T Aron</dc:creator>
<dc:creator>Yasin El Abiead</dc:creator>
<dc:creator>Sawyer Farmer</dc:creator>
<dc:creator>Antonio González</dc:creator>
<dc:creator>Cameron Martino</dc:creator>
<dc:creator>Ipsita Mohanty</dc:creator>
<dc:creator>Ceth W Parker</dc:creator>
<dc:creator>Lucas Patel</dc:creator>
<dc:creator>Paulo Wender Portal Gomes</dc:creator>
<dc:creator>Robin Schmid</dc:creator>
<dc:creator>Tara Schwartz</dc:creator>
<dc:creator>Jennifer Zhu</dc:creator>
<dc:creator>Michael R Barratt</dc:creator>
<dc:creator>Kathleen H Rubins</dc:creator>
<dc:creator>Hiutung Chu</dc:creator>
<dc:creator>Fathi Karouia</dc:creator>
<dc:creator>Kasthuri Venkateswaran</dc:creator>
<dc:creator>Pieter C Dorrestein</dc:creator>
<dc:creator>Rob Knight</dc:creator>
<dc:date>2025-02-28</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The International Space Station has a unique and extreme microbial and chemical environment driven by use patterns</dc:title>
<dc:identifier>pmid:40020666</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.01.039</dc:identifier>
</item>
<item>
<title>Strengthening Global Partnerships to Combat Cardiovascular Disease: A Call to Action</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40019449/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Feb 19:S0735-1097(25)00203-7. doi: 10.1016/j.jacc.2025.01.019. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40019449/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40019449</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.019>10.1016/j.jacc.2025.01.019</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40019449</guid>
<pubDate>Fri, 28 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Cathleen Biga</dc:creator>
<dc:creator>Jagat Narula</dc:creator>
<dc:date>2025-02-28</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Strengthening Global Partnerships to Combat Cardiovascular Disease: A Call to Action</dc:title>
<dc:identifier>pmid:40019449</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.019</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40019276/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 3;150(23):1898-1903. doi: 10.1161/CIRCULATIONAHA.124.072974. Epub 2024 Dec 2.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40019276/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40019276</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072974>10.1161/CIRCULATIONAHA.124.072974</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40019276</guid>
<pubDate>Fri, 28 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-28</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:40019276</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072974</dc:identifier>
</item>
<item>
<title>Better Late Than Early? The Role of the Vascular Endothelium in Late-Onset Menopause</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40014681/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 28;136(5):470-472. doi: 10.1161/CIRCRESAHA.125.326197. Epub 2025 Feb 27.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40014681/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40014681</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.125.326197>10.1161/CIRCRESAHA.125.326197</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40014681</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Gurleen Kaur</dc:creator>
<dc:creator>Naomi M Hamburg</dc:creator>
<dc:creator>Emily S Lau</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Better Late Than Early? The Role of the Vascular Endothelium in Late-Onset Menopause</dc:title>
<dc:identifier>pmid:40014681</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.125.326197</dc:identifier>
</item>
<item>
<title>Roles of Sirtuins in Cardiovascular Diseases: Mechanisms and Therapeutics</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40014680/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>Cardiovascular diseases (CVDs) are experiencing a rapid surge and are widely recognized as the leading cause of mortality in the current aging society. Given the multifactorial etiology of CVDs, understanding the intricate molecular and cellular mechanisms is imperative. Over the past 2 decades, many scientists have focused on Sirtuins, a family of nicotinamide adenine dinucleotide-dependent deacylases. Sirtuins are highly conserved across species, from yeasts to primates, and play a crucial...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 28;136(5):524-550. doi: 10.1161/CIRCRESAHA.124.325440. Epub 2025 Feb 27.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiovascular diseases (CVDs) are experiencing a rapid surge and are widely recognized as the leading cause of mortality in the current aging society. Given the multifactorial etiology of CVDs, understanding the intricate molecular and cellular mechanisms is imperative. Over the past 2 decades, many scientists have focused on Sirtuins, a family of nicotinamide adenine dinucleotide-dependent deacylases. Sirtuins are highly conserved across species, from yeasts to primates, and play a crucial role in linking aging and diseases. Sirtuins participate in nearly all key physiological and pathological processes, ranging from embryogenic development to stress response and aging. Abnormal expression and activity of Sirtuins exist in many aging-related diseases, while their activation has shown efficacy in mitigating these diseases (eg, CVDs). In terms of research, this field has maintained fast, sustained growth in recent years, from fundamental studies to clinical trials. In this review, we present a comprehensive, up-to-date discussion on the biological functions of Sirtuins and their roles in regulating cardiovascular biology and CVDs. Furthermore, we highlight the latest advancements in utilizing Sirtuin-activating compounds and nicotinamide adenine dinucleotide boosters as potential pharmacological targets for preventing and treating CVDs. The key unresolved issues in the field-from the chemicobiological regulation of Sirtuins to Sirtuin-targeted CVD investigations-are also discussed. This timely review could be critical in understanding the updated knowledge of Sirtuin biology in CVDs and facilitating the clinical accessibility of Sirtuin-targeting interventions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40014680/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40014680</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325440>10.1161/CIRCRESAHA.124.325440</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40014680</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Yang-Nan Ding</dc:creator>
<dc:creator>Hui-Yu Wang</dc:creator>
<dc:creator>Xiao-Feng Chen</dc:creator>
<dc:creator>Xiaoqiang Tang</dc:creator>
<dc:creator>Hou-Zao Chen</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Roles of Sirtuins in Cardiovascular Diseases: Mechanisms and Therapeutics</dc:title>
<dc:identifier>pmid:40014680</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325440</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40014679/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 28;136(5):453-454. doi: 10.1161/RES.0000000000000710. Epub 2025 Feb 27.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40014679/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40014679</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000710>10.1161/RES.0000000000000710</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40014679</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-27</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:40014679</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000710</dc:identifier>
</item>
<item>
<title>2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40014670/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>AIM: The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" incorporates new evidence since the "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction" and the corresponding "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes" and the "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction."...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" incorporates new evidence since the "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction" and the corresponding "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes" and the "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction." The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" and the "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization" retire and replace, respectively, the "2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease."</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A comprehensive literature search was conducted from July 2023 to April 2024. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STRUCTURE: Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40014670/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40014670</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001309>10.1161/CIR.0000000000001309</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40014670</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Sunil V Rao</dc:creator>
<dc:creator>Michelle L O'Donoghue</dc:creator>
<dc:creator>Marc Ruel</dc:creator>
<dc:creator>Tanveer Rab</dc:creator>
<dc:creator>Jaqueline E Tamis-Holland</dc:creator>
<dc:creator>John H Alexander</dc:creator>
<dc:creator>Usman Baber</dc:creator>
<dc:creator>Heather Baker</dc:creator>
<dc:creator>Mauricio G Cohen</dc:creator>
<dc:creator>Mercedes Cruz-Ruiz</dc:creator>
<dc:creator>Leslie L Davis</dc:creator>
<dc:creator>James A de Lemos</dc:creator>
<dc:creator>Tracy A DeWald</dc:creator>
<dc:creator>Islam Y Elgendy</dc:creator>
<dc:creator>Dmitriy N Feldman</dc:creator>
<dc:creator>Abhinav Goyal</dc:creator>
<dc:creator>Ijeoma Isiadinso</dc:creator>
<dc:creator>Venu Menon</dc:creator>
<dc:creator>David A Morrow</dc:creator>
<dc:creator>Debabrata Mukherjee</dc:creator>
<dc:creator>Elke Platz</dc:creator>
<dc:creator>Susan B Promes</dc:creator>
<dc:creator>Sigrid Sandner</dc:creator>
<dc:creator>Yader Sandoval</dc:creator>
<dc:creator>Rachel Schunder</dc:creator>
<dc:creator>Binita Shah</dc:creator>
<dc:creator>Jason P Stopyra</dc:creator>
<dc:creator>Amy W Talbot</dc:creator>
<dc:creator>Pam R Taub</dc:creator>
<dc:creator>Marlene S Williams</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:40014670</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001309</dc:identifier>
</item>
<item>
<title>2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40013746/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>AIM: The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" incorporates new evidence since the "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction" and the corresponding "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes" and the "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction."...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Feb 27:S0735-1097(24)10424-X. doi: 10.1016/j.jacc.2024.11.009. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" incorporates new evidence since the "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction" and the corresponding "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes" and the "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction." The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" and the "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization" retire and replace, respectively, the "2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease."</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A comprehensive literature search was conducted from July 2023 to April 2024. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STRUCTURE: Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40013746/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40013746</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.11.009>10.1016/j.jacc.2024.11.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40013746</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Sunil V Rao</dc:creator>
<dc:creator>Michelle L O'Donoghue</dc:creator>
<dc:creator>Marc Ruel</dc:creator>
<dc:creator>Tanveer Rab</dc:creator>
<dc:creator>Jaqueline E Tamis-Holland</dc:creator>
<dc:creator>John H Alexander</dc:creator>
<dc:creator>Usman Baber</dc:creator>
<dc:creator>Heather Baker</dc:creator>
<dc:creator>Mauricio G Cohen</dc:creator>
<dc:creator>Mercedes Cruz-Ruiz</dc:creator>
<dc:creator>Leslie L Davis</dc:creator>
<dc:creator>James A de Lemos</dc:creator>
<dc:creator>Tracy A DeWald</dc:creator>
<dc:creator>Islam Y Elgendy</dc:creator>
<dc:creator>Dmitriy N Feldman</dc:creator>
<dc:creator>Abhinav Goyal</dc:creator>
<dc:creator>Ijeoma Isiadinso</dc:creator>
<dc:creator>Venu Menon</dc:creator>
<dc:creator>David A Morrow</dc:creator>
<dc:creator>Debabrata Mukherjee</dc:creator>
<dc:creator>Elke Platz</dc:creator>
<dc:creator>Susan B Promes</dc:creator>
<dc:creator>Sigrid Sandner</dc:creator>
<dc:creator>Yader Sandoval</dc:creator>
<dc:creator>Rachel Schunder</dc:creator>
<dc:creator>Binita Shah</dc:creator>
<dc:creator>Jason P Stopyra</dc:creator>
<dc:creator>Amy W Talbot</dc:creator>
<dc:creator>Pam R Taub</dc:creator>
<dc:creator>Marlene S Williams</dc:creator>
<dc:creator>Peer Review Committee Members</dc:creator>
<dc:creator>Hani Jneid</dc:creator>
<dc:creator>Craig J Beavers</dc:creator>
<dc:creator>Faisal M Merchant</dc:creator>
<dc:creator>Theresa Beckie</dc:creator>
<dc:creator>Noreen Nazir</dc:creator>
<dc:creator>Jim Blankenship</dc:creator>
<dc:creator>Derek So</dc:creator>
<dc:creator>Deborah Diercks</dc:creator>
<dc:creator>Matthew Tomey</dc:creator>
<dc:creator>Bruce Lo</dc:creator>
<dc:creator>Frederick Welt</dc:creator>
<dc:creator>Clauden Louis</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:40013746</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.11.009</dc:identifier>
</item>
<item>
<title>2025 Acute Coronary Syndromes Guideline-at-a-Glance</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40013745/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Feb 27:S0735-1097(25)00202-5. doi: 10.1016/j.jacc.2025.01.018. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40013745/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40013745</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.018>10.1016/j.jacc.2025.01.018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40013745</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Dharam J Kumbhani</dc:creator>
<dc:creator>Morgane Cibotti-Sun</dc:creator>
<dc:creator>Mykela M Moore</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>2025 Acute Coronary Syndromes Guideline-at-a-Glance</dc:title>
<dc:identifier>pmid:40013745</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.018</dc:identifier>
</item>
<item>
<title>Endomyocardial fibrosis: recent advances and future therapeutic targets</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40011660/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>Endomyocardial fibrosis, first described >;75 years ago, is a cause of restrictive cardiomyopathy with an unclear aetiopathogenesis that is most commonly found in children and adolescents from tropical regions of Africa, Asia and South America. The epidemiological trends of this cardiomyopathy are difficult to ascertain. The characteristic hallmark of endomyocardial fibrosis is ventricular fibrosis that causes diastolic dysfunction and atrioventricular regurgitation. Although advances in medical...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Feb 26. doi: 10.1038/s41569-025-01138-x. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Endomyocardial fibrosis, first described >;75 years ago, is a cause of restrictive cardiomyopathy with an unclear aetiopathogenesis that is most commonly found in children and adolescents from tropical regions of Africa, Asia and South America. The epidemiological trends of this cardiomyopathy are difficult to ascertain. The characteristic hallmark of endomyocardial fibrosis is ventricular fibrosis that causes diastolic dysfunction and atrioventricular regurgitation. Although advances in medical treatment for heart failure and more tailored surgical techniques to treat the condition have increased survival, the outcomes in affected patients remain poor. A major focus of research is the identification of biomarkers of preclinical disease and new therapeutic targets. Collaborative multidisciplinary research and cross-learning from other fibrotic conditions should impart knowledge and help to improve the survival rates and the quality of life of patients with endomyocardial fibrosis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40011660/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40011660</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01138-x>10.1038/s41569-025-01138-x</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40011660</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Ana O Mocumbi</dc:creator>
<dc:creator>Viviane Tiemi Hotta</dc:creator>
<dc:creator>Gene Bukhman</dc:creator>
<dc:creator>Ntobeko Ntusi</dc:creator>
<dc:creator>Magdi H Yacoub</dc:creator>
<dc:creator>Paulo Correia-de-Sá</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Endomyocardial fibrosis: recent advances and future therapeutic targets</dc:title>
<dc:identifier>pmid:40011660</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01138-x</dc:identifier>
</item>
<item>
<title>The Dynamic Equilibrium of Heart Valve Transplantation: A Balance of Similarities and Differences</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40010932/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Mar 4;85(8):870-872. doi: 10.1016/j.jacc.2025.01.012.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40010932/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40010932</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.012>10.1016/j.jacc.2025.01.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40010932</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Emily A Downs</dc:creator>
<dc:creator>Melanie D Everitt</dc:creator>
<dc:creator>Matthew L Stone</dc:creator>
<dc:creator>Shelley D Miyamoto</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>The Dynamic Equilibrium of Heart Valve Transplantation: A Balance of Similarities and Differences</dc:title>
<dc:identifier>pmid:40010932</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.012</dc:identifier>
</item>
<item>
<title>Domino Heart Valve Transplant in Children With Congenital Valve Disease: Short-Term Outcomes, Growth, and Immunosensitization</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40010931/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250303131430&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Mar 4;85(8):866-869. doi: 10.1016/j.jacc.2024.12.008.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40010931/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250303131430&v=2.18.0.post9+e462414">40010931</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.12.008>10.1016/j.jacc.2024.12.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40010931</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>David M Kalfa</dc:creator>
<dc:creator>Marc Richmond</dc:creator>
<dc:creator>Elizabeth M Cordoves</dc:creator>
<dc:creator>Teresa Lee</dc:creator>
<dc:creator>Warren Zuckerman</dc:creator>
<dc:creator>Stephan Juergensen</dc:creator>
<dc:creator>Amee Shah</dc:creator>
<dc:creator>Emile A Bacha</dc:creator>
<dc:creator>Andrew B Goldstone</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Domino Heart Valve Transplant in Children With Congenital Valve Disease: Short-Term Outcomes, Growth, and Immunosensitization</dc:title>
<dc:identifier>pmid:40010931</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.12.008</dc:identifier>
</item>





























</channel>
</rss>